Consolidated Balance Sheet (Unaudited) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 70	$ 289
Trade accounts and other receivables	1,021	1,002
Allowance for doubtful accounts	(10)	(6)
Trade accounts and other receivables – net	1,011	996
Inventories	157	125
Other current assets and deferred charges	165	170
Total current assets	1,403	1,580
Investments	5,176	6,235
Property, plant, and equipment	42,384	41,510
Accumulated depreciation and amortization	(13,277)	(12,310)
Property, plant, and equipment – net	29,107	29,200
Intangible assets – net of accumulated amortization	7,531	7,959
Regulatory assets, deferred charges, and other	1,103	1,066
Total assets	44,320	46,040
Current liabilities:
Accounts payable	464	552
Accrued liabilities	965	1,276
Commercial Paper	40	0
Long-term debt due within one year	392	2,140
Total current liabilities	1,861	3,968
Long-term debt	21,951	20,148
Deferred income tax liabilities	1,846	1,782
Regulatory liabilities, deferred income, and other	3,764	3,778
Contingent liabilities (Note 13)
Stockholders’ equity:
Preferred Stock	35	35
Common stock ($1 par value; 1,470 million shares authorized at September 30, 2020 and December 31, 2019; 1,248 million shares issued at September 30, 2020 and 1,247 million shares issued at December 31, 2019)	1,248	1,247
Capital in excess of par value	24,359	24,323
Retained deficit	(12,376)	(11,002)
Accumulated other comprehensive income (loss)	(160)	(199)
Treasury Stock, Value	(1,041)	(1,041)
Total stockholders’ equity	12,065	13,363
Noncontrolling interests in consolidated subsidiaries	2,833	3,001
Total equity	14,898	16,364
Total liabilities and equity	$ 44,320	$ 46,040